✦ LIBER ✦

A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors

✍ Scribed by von Mehren, Margaret; Britten, Carolyn D.; Pieslor, Peter; Saville, Wayne; Vassos, Artemios; Harris, Sarah; Galluppi, Gerald R.; Darif, Mohamed; Wainberg, Zev A.; Cohen, Roger B.; Leong, Stephen

Book ID: 121566884
Publisher: Springer US
Year: 2014
Tongue: English
Weight: 229 KB
Volume: 32
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-014-0064-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1227 A phase 1, dose-escalation study of

1227 A phase 1, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in patients with relapsed or refractory solid tumours

✍ M. von Mehren; C. Britten; P. Piesolor; K. Balogh; A. Bartok; S. Harris; X. Li; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Phase 1, open-label study of MEDI-547 in

Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors

✍ Christina M. Annunziata, Elise C. Kohn, Patricia LoRusso, Nicole D. Houston, Rob 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 154 KB

Dose-escalation of human anti-interferon

Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study

✍ Goldberg, Avram; Geppert, Thomas; Schiopu, Elena; Frech, Tracy; Hsu, Vivien; Sim 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 602 KB

166 A phase I dose-escalation study of a

166 A phase I dose-escalation study of anti-a5β1 integrin monoclonal antibody (M200) in patients with refractory solid tumors

✍ A. Ricart; G. Liu; A. Tolcher; G. Schwartz; J. Harris; R. Stagg; E. Rowinsky; G. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 297 KB

Weekly bortezomib in combination with te

Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: a multicentre, phase 1/2, open-label, dose-escalation study

✍ Irene M Ghobrial; Edie Weller; Ravi Vij; Nikhil C Munshi; Ranjit Banwait; Meghan 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 210 KB

Phase 1, open-label, dose-escalation, an

Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors

✍ Bendell, Johanna C.; Hong, David S.; Burris, Howard A.; Naing, Aung; Jones, Suza 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 189 KB